Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04502095 · ClinicalTrials.gov registry record · Phase 4
Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy
A Phase 4 study, sponsored by Roswell Park Cancer Institute.
- Completed
- Registry status
- Phase 4
- Development phase
- 89
- Enrollment target
NCT04502095 is a Phase 4 study that has completed, run by Roswell Park Cancer Institute. The registered enrollment target is 89 participants.
The verdict
NCT04502095, a Phase 4 study, has completed, sponsored by Roswell Park Cancer Institute.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 89 participants
- Enrollment target
Study Summary
This trial investigates whether a one-month course of preventative (prophylactic) antibiotics helps to reduce urinary tract infections after robot-assisted surgery to remove all of the bladder as well as nearby tissues and organs (radical cystectomy). Urinary tract infections are a common occurrence after robot-assisted radical cystectomy. Antibiotics such as trimethoprim-sulfamethoxazole or nitrofurantoin may prevent or control infections in patients with urinary tract infection and may help improve their response to radical cystectomy. Information gained from this study may help researchers to predict patient complications and identify better ways to manage these complications.
Interventions
- DRUG Clindamycin
- DRUG Nitrofurantoin
- DRUG Levofloxacin
- OTHER Diary
- DRUG Ertapenem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2020-09-02 |
| Est. Completion | 2025-03-13 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04502095
The ClinicalTrials.gov registry entry for NCT04502095 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Clindamycin is the first listed.
NCT04502095 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04502095 about?
NCT04502095 is a clinical study titled "Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy". This trial investigates whether a one-month course of preventative (prophylactic) antibiotics helps to reduce urinary tract infections after robot-assisted surgery to remove all of the bladder as well as nearby tissues and organs (radical cystectomy). Urinary tract infections are a common occurrence...
What is the current status of trial NCT04502095?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 89 participants. The study started on 2020-09-02. Estimated completion is 2025-03-13.
What interventions are being tested in trial NCT04502095?
The interventions under investigation include: Clindamycin (DRUG), Nitrofurantoin (DRUG), Levofloxacin (DRUG), Diary (OTHER), Ertapenem (DRUG).
Who is sponsoring clinical trial NCT04502095?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.